Massachusetts Based Foghorn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Foghorn stock gains as Eli Lilly picks lung cancer drug (NASDAQ:FHTX)

Foghorn stock gains as Eli Lilly picks lung cancer drug (NASDAQ:FHTX)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomEli lilly and companyEli lilly and company in madridEli lillyMassachusetts based foghorn

Cardiac Complication Leads FDA to Place Foghorn Cancer Drug Under Partial Hold

A clinical trial for a Foghorn Therapeutics cancer drug is under a partial FDA hold after a patient in the early-stage study developed a cardiovascular complication. It’s the biotech’s second partial hold in the past year.

United statesUnited kingdomFoghorn therapeuticsMassachusetts based foghornWeight lossMedical devicesHealthcare innovationMedcity newsMedcity newsSan franciscoLife sciencesRock healthStartup adviceStartup fundingPatient monitoring systemOtion sensors

Eli Lilly steers into Foghorn s gene traffic control drugs with $380M pact in cancer

Eli Lilly is building its cancer drug pipeline via a research alliance with Foghorn Therapeutic, a biotech whose technology discovers drugs addressing targets in a cellular system that regulate the way genes are turned on and off. In paying its new partner $380 million up front, Lilly is also placing yet another bet on targeted protein degradation drugs.

Dana farber cancer instituteUnited statesUnited kingdomEli lillyJacob van naardenStanford universityIndianapolis based lillyMassachusetts based foghornLoxo oncologyVan naardenLilly oncologyKymera therapeuticsNurix therapeuticsLycia therapeuticsWeight lossMedical devices